Acute Ischemic Stroke

Stroke drug demonstrates safety in clinical trial

A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...

Feb 20, 2018
popularity41 comments 0

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Enduring cold temperatures alters fat cell epigenetics

A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...